Caisse de depot et placement du Quebec

Position in RPRX — Royalty Pharma plc

CIK 898286 Montreal, A8

Position in RPRX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$10,458,947

-$24,768,561 QoQ

Shares Held

218,031

-76.1% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Caisse de depot et placement du Quebec holds $667,145,858 across 11 Biotechnology names. RPRX ranks #7 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	329,018	$254,212,467
2	INCY	Incyte Corp	1,520,486	$143,108,142
3	EXEL	Exelixis, Inc.	2,542,819	$109,061,506
4	HALO	Halozyme Therapeutics, Inc.	1,121,200	$72,463,156
5	BMRN	Biomarin Pharmaceutical Inc	945,603	$53,417,113
6	VRTX	Vertex Pharmaceuticals Inc / Ma	50,917	$22,736,477
7	RPRX	Royalty Pharma plc This page	218,031	$10,458,947
8	ALNY	Alnylam Pharmaceuticals, Inc.	1,988	$657,769

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,458,947	218,031	-76.1%	Shares	Sole	2026-05-14
2025-12-31	$35,227,508	911,685	+240.6%	Shares	Sole	2026-02-17
2025-09-30	$9,444,456	267,700	+241.8%	Shares	Sole	2025-11-14
2025-06-30	$2,822,121	78,327	-89.3%	Shares	Sole	2025-08-14
2025-03-31	$22,768,513	731,401	+2.6%	Shares	Sole	2025-05-14
2024-12-31	$18,183,145	712,785	+671.0%	Shares	Sole	2025-02-14
2024-03-31	$2,807,767	92,452	+29.5%	Shares	Sole	2024-05-14
2023-03-31	$2,572,542	71,400	+276.0%	Shares	Sole	2023-05-12
2021-03-31	$828,300	18,989	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.